RecallRadar

FDA Drug recall D-0750-2021

Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA,…

On 2021-08-25 the FDA classified a Class II recall of Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA,… by Dr Reddy S Laboratories, citing failed Tablet/Capsule Specification: Some tablets are shaved.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0750-2021
ClassificationClass II
Statusterminated
Initiated2021-07-19
Published2021-08-25
Last updated2026-09-13 11:52 UTC
CompanyDr Reddy S Laboratories
DistributionUS

Product

Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15.

Reason

Failed Tablet/Capsule Specification: Some tablets are shaved

Identifiers

ndc55111-179-30
ndc55111-179-15
ndc55111-179-03
ndc55111-179-10
ndc55111-180-30
ndc55111-180-15
ndc55111-180-03
ndc55111-180-10
code_infoLot #: T2000471, exp date 09/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0750-2021%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.